NIH participates in the Global Alliance for Chronic Diseases (GACD), a collection of publicly funded research agencies that supports innovative research collaborations to address the prevention and treatment of chronic diseases in vulnerable populations.
View and filter GACD-supported projects.
Mental Health | Lung Disease | Type 2 Diabetes | Hypertension
GACD Mental Health Research
GACD funding agencies are accepting implementation research proposals on child, adolescent and adult age onset mental disorders including, but not limited to, dementia, depression, schizophrenia, bipolar disorders, alcohol- and drug-use disorders, etc., in low- and middle-income countries and/or in vulnerable populations in high-income countries.
GACD Lung Disease Research
GACD member organizations will accept implementation research proposals to address lung diseases related to environmental exposures, including indoor and outdoor air pollution and tobacco. Eligibility and application deadlines will vary by organization, and details will be released over time by each organization.
GACD Type 2 Diabetes Research
GACD member organizations, including NIH, recently solicited applications on type 2 diabetes with a focus on improving the science around implementation of existing interventions. NIH applications were accepted through the trans-NIH Initiative on Dissemination and Implementation Science for February 2014 application due dates.
GACD Hypertension Research
GACD members chose hypertension as their first joint funding initiative. Grants were announced in June 2012.
Updated April 18, 2018